BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19800225)

  • 21. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
    Sekar N; Veldhuis JD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.
    Huang C; Zhang Y; Gong Z; Sheng X; Li Z; Zhang W; Qin Y
    Biochem Biophys Res Commun; 2006 Sep; 348(2):571-8. PubMed ID: 16890192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor up-regulates expression of low-density lipoprotein receptors on HepG2 cells.
    Liao W; Florén CH
    Hepatology; 1993 May; 17(5):898-907. PubMed ID: 8387950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
    Liu J; Grove RI; Vestal RE
    Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
    Cobb JE; Blanchard SG; Boswell EG; Brown KK; Charifson PS; Cooper JP; Collins JL; Dezube M; Henke BR; Hull-Ryde EA; Lake DH; Lenhard JM; Oliver W; Oplinger J; Pentti M; Parks DJ; Plunket KD; Tong WQ
    J Med Chem; 1998 Dec; 41(25):5055-69. PubMed ID: 9836622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCAP ligands are potent new lipid-lowering drugs.
    Grand-Perret T; Bouillot A; Perrot A; Commans S; Walker M; Issandou M
    Nat Med; 2001 Dec; 7(12):1332-8. PubMed ID: 11726974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical pathways in the antiatherosclerotic effect of berberine.
    Guo Y; Wang QZ; Li FM; Jiang X; Zuo YF; Wang L
    Chin Med J (Engl); 2008 Jul; 121(13):1197-203. PubMed ID: 18710638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of olive antihyperlipidemia capsule on low and high density lipoprotein receptor in rat liver gene expression in hyperlipmia rat liver].
    Zhang JS
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(6):519-22. PubMed ID: 17552160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
    Abidi P; Zhang F; Li C; Liu J
    Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression.
    Asano S; Ban H; Kino K; Ioriya K; Muraoka M
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1062-5. PubMed ID: 19167888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
    Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of C-9 Modified Berberine Derivatives as Novel Lipid-Lowering Agents.
    Li DD; Yu P; Xu H; Wang ZZ; Xiao W; Zhao LG
    Chem Pharm Bull (Tokyo); 2021 Jan; 69(1):59-66. PubMed ID: 33087641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against Coxsackievirus B.
    Zeng QX; Wang HQ; Wei W; Guo TT; Yu L; Wang YX; Li YH; Song DQ
    Bioorg Chem; 2020 Jan; 95():103490. PubMed ID: 31855821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
    Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
    Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3',4',5'-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents.
    Ty N; Dupeyre G; Chabot GG; Seguin J; Tillequin F; Scherman D; Michel S; Cachet X
    Bioorg Med Chem; 2008 Aug; 16(15):7494-503. PubMed ID: 18583138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
    Liu W; Liu P; Tao S; Deng Y; Li X; Lan T; Zhang X; Guo F; Huang W; Chen F; Huang H; Zhou SF
    Arch Biochem Biophys; 2008 Jul; 475(2):128-34. PubMed ID: 18471986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gossypin up-regulates LDL receptor through activation of ERK pathway: a signaling mechanism for the hypocholesterolemic effect.
    Lu N; Li Y; Qin H; Zhang YL; Sun CH
    J Agric Food Chem; 2008 Dec; 56(23):11526-32. PubMed ID: 19007237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.